Health
Larger panel finds more gene mutations, treatment targets for leukemia – Medical Xpress
A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine tune treatment for a variety of cancers…
A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia, investigators report.
The 523-gene panel, developed by San Diego-based biotech company Illumina, which includes all genes known to potentially cause cancer, can be readily adopted for use in clinical laboratories to diagnose acute myeloid leukemia, or AML, the…
-
Business24 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General20 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News24 hours agoRock royalty is rolling into Hervey Bay
-
Noosa News23 hours agoNew FLC President has regional lens – Proctor